Rubrik: europharm
(Treffer aus pharmind, Nr. 12, Seite 1718 (2015))
Impact analysis respective the switch from NtA or CTD submissions to eCTD submissions for medicinal products * S. Rauch, "Impact analysis respective the switch from NtA or CTD submissions (Paper or NeeS) to eCTD submissions for medicinal products for human use in the EU being newly applied or already authorized–exemplified for Germany (BfArM)", Master Thesis, 2014. / Rauch • Impact Analysis · Rauch S · MSD SHARP & DOHME GMBH, Haar